Publications by authors named "John Borg"

Claim this Profile
P
Plastic ingestion by Cory's and Scopoli's shearwaters (Calonectris spp.) from the north-eastern Atlantic Ocean and Mediterranean Sea.
Jan A van Franeker, Edward Soldaat, Joël Bried, Jacob González-Solís, Francis Zino, John J Borg

Mar Pollut Bull· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure of wetlands important for nonbreeding waterbirds to sea-level rise in the Mediterranean.
Fabien Verniest, Thomas Galewski, Olivier Boutron, Laura Dami, Pierre Defos du Rau, John J Borg

Conserv Biol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab Safety in Renal Cell Carcinoma: A Case Report.
James Debono, Dustin Balzan, John Joseph Borg, Stephen Falzon, Dania Al-Haddad

J Pharm Technol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pharmacological treatment of granulomatosis with polyangiitis: a review of clinical trials registered in clinicaltrials.gov and the International Clinical Trials Registry Platform.
Janet Sultana, Nikita Camilleri, Salvatore Crisafulli, John Joseph Borg, Silvan Spagnol, Joseph Borg

Ther Adv Rare Dis· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global assessment of marine plastic exposure risk for oceanic birds.
Bethany L Clark, Ana P B Carneiro, Elizabeth J Pearmain, Marie-Morgane Rouyer, Thomas A Clay, John J Borg

Nat Commun· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Pharmacology of autoimmune and neuroinflammatory disease from a preclinical and clinical perspective.
Martin Šíma, Andrea Laslop, John Joseph Borg, Silvester Poništ, Daniela Melchiorri

Front Pharmacol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The changing landscape of treatment options in childhood acute lymphoblastic leukaemia.
Benjamin Micallef, Robert Nisticò, Sinan B Sarac, Ole W Bjerrum, Dianne Butler, John Joseph Borg

Drug Discov Today· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Healthy Gut for a Healthy Brain: Preclinical, Clinical and Regulatory Aspects.
Carla Petrella, Stefano Farioli-Vecchioli, Giusy Ylenia Cisale, Georgios Strimpakos, John Joseph Borg

Curr Neuropharmacol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aducanumab for Alzheimer's disease: A regulatory perspective.
Robert Nisticò, John Joseph Borg

Pharmacol Res· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cadaveric Evaluation of a Device Supporting Gasless Transoral Endoscopic Thyroidectomy.
Christian Camenzuli, Josef Attard, John P Borg, Pierre Schembri Wismayer, Jonathan Borg

Surg Innov· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory sciences and translational pharmacogenetics: amitriptyline as a case in point.
Luana Mifsud Buhagiar, Benjamin Micallef, John Joseph Borg, Helen Vella, Anthony Serracino Inglott

Drug Metab Pers Ther· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmaceutical issues during the review of European Marketing Authorisation Applications in Malta.
Michael Chetcuti, Anthony Serracino-Inglott, Gavril Flores, John J Borg

Pharm Dev Technol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opinions of Maltese doctors and pharmacists on medication errors.
Amy Tanti, Miriam Camilleri, Andrew A Borg, Benjamin Micallef, Gavril Flores, John Joseph Borg

Int J Risk Saf Med· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality Issues Identified During the Evaluation of Biosimilars by the European Medicines Agency's Committee for Medicinal Products for Human Use.
Mark Cilia, Sol Ruiz, Peter Richardson, Tomas Salmonson, Anthony Serracino-Inglott, John Joseph Borg

AAPS PharmSciTech· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changing paradigms in bioequivalence trials submitted to the EMA for evaluation - A clinical and regulatory perspective.
Nathaniel Refalo, Daniel Chetcuti, Amy Tanti, Anthony Serracino-Inglott, John Joseph Borg

Saudi Pharm J· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Rapid, Cost-Effective Pre-Clinical Method to Screen for Pro- or Antiarrhythmic Effects of Substances in an Isolated Heart Preparation.
John Joseph Borg

Sci Pharm· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodal management as requirement for the clinical use of anticachexia drugs - a regulatory and a clinical perspective.
John J Borg, Stefan D Anker, Giuseppe Rosano, Anthony Serracino-Inglott, Florian Strasser

Curr Opin Support Palliat Care· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Manufacturing, characterization and control of cell-based medicinal products: challenging paradigms toward commercial use.
Paula Salmikangas, Margarida Menezes-Ferreira, Ilona Reischl, Asterios Tsiftsoglou, Jan Kyselovic, John Joseph Borg

Regen Med· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Union pharmacovigilance capabilities: potential for the new legislation.
John Joseph Borg, Amy Tanti, Dimitrios Kouvelas, Calin Lungu, Michal Pirozynski

Ther Adv Drug Saf· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Licensing of Generic Medicines: Are There Any Challenges Left? A Pharmaceutical Regulatory Perspective.
John Joseph Borg, Paolo Tomasi, Luca Pani, George Aislaitner, Michal Pirozynski

Sci Pharm· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reflections on Decisions Made on the Well-Established Use of Medicinal Products by EU Regulators and the ECJ.
John Joseph Borg, Andrea Laslop, Luca Pani, Romaldas Maciulaitis, Daniela Melchiorri

Sci Pharm· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Teaching pharmacy in Malta '1676 - 1990s' Part II.
John Joseph Borg

Pharm Hist (Lond)· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Teaching pharmacy in Malta 1676-1990s: Part I.
John Joseph Borg

Pharm Hist (Lond)· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: "EU's new pharmacovigilance legislation: considerations for biosimilars".
John Joseph Borg, Anthony Serracino-Inglott, Lilian M Azzopardi, Christian K Schneider

Drug Saf· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory evaluation of Glybera in Europe - two committees, one mission.
Daniela Melchiorri, Luca Pani, Paolo Gasparini, Giulio Cossu, Janis Ancans, John Joseph Borg

Nat Rev Drug Discov· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis